{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:30:19Z","timestamp":1791156619717,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.ejphar.2006.07.024","type":"journal-article","created":{"date-parts":[[2006,7,26]],"date-time":"2006-07-26T13:13:33Z","timestamp":1153919613000},"page":"60-68","source":"Crossref","is-referenced-by-count":33,"title":["Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice"],"prefix":"10.1016","volume":"546","author":[{"given":"Victoria L.","family":"Haller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L.","family":"Cichewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra P.","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2006.07.024_bib1","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1021\/jm00038a020","article-title":"(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability","volume":"37","author":"Abadji","year":"1994","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2006.07.024_bib2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/jpet.303.1.340","article-title":"Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta (9)-tetrahydrocannabinol administration","volume":"303","author":"Anikwue","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.07.024_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-2999(02)01369-9","article-title":"Arvanil-induced inhibiton of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB1\/CB2 receptors","volume":"439","author":"Brooks","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.07.024_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/28393","article-title":"Control of pain initiation by endogenous cannabinoids","volume":"394","author":"Calignano","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2006.07.024_bib5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0022-3565(24)38212-6","article-title":"Enhancement of mu opioid antinociception by oral delta (9)-tetrahydrocannabinol: dose-response analysis and receptor identification","volume":"289","author":"Cichewicz","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.07.024_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-3565(24)29518-5","article-title":"Changes in opioid and cannabinoid receptor protein following short-term combination treatment with delta (9)-tetrahydrocannabinol and morphine","volume":"297","author":"Cichewicz","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.07.024_bib7","first-page":"586","article-title":"In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity","volume":"277","author":"Compton","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"16","key":"10.1016\/j.ejphar.2006.07.024_bib8","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1073\/pnas.161191698","article-title":"Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase","volume":"98","author":"Cravatt","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2006.07.024_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0014-5793(00)02082-2","article-title":"Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity","volume":"483","author":"De Petrocellis","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2006.07.024_bib10","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2006.07.024_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0005-2760(98)00042-3","article-title":"\u2018Endocannabinoids\u2019, and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance","volume":"1392","author":"Di Marzo","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2006.07.024_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0014-2999(00)00687-7","article-title":"Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide","volume":"406","author":"Di Marzo","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.07.024_bib13","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1046\/j.1471-4159.2000.0752434.x","article-title":"Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain","volume":"75","author":"Di Marzo","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2006.07.024_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0090-6980(00)00054-X","article-title":"Cannabimimetic fatty acid derivatives in cancer and inflammation","volume":"61","author":"Di Marzo","year":"2000","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.ejphar.2006.07.024_bib15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF01965625","article-title":"The antialgesic drugs: human therapeutic correlates of their potency in laboratory animal models of hyperalgesia","volume":"20","author":"Dubinsky","year":"1987","journal-title":"Agents Actions"},{"key":"10.1016\/j.ejphar.2006.07.024_bib16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1124\/jpet.104.078980","article-title":"Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3\u2032-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide","volume":"313","author":"Fegley","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.07.024_bib17","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2006.07.024_bib18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00045391-200501000-00008","article-title":"Mechanism of action of paracetamol","volume":"12","author":"Graham","year":"2005","journal-title":"Am. J. Ther."},{"issue":"18","key":"10.1016\/j.ejphar.2006.07.024_bib19","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/S0024-3205(03)00651-9","article-title":"Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat","volume":"73","author":"Helyes","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2006.07.024_bib20","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"36","key":"10.1016\/j.ejphar.2006.07.024_bib21","doi-asserted-by":"crossref","first-page":"31405","DOI":"10.1074\/jbc.M501489200","article-title":"Conversion of acetaminophen to the bioactive N-Acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system","volume":"280","author":"H\u00f6gest\u00e4tt","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2006.07.024_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0006-8993(00)01981-8","article-title":"Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, \u03949-THC and anandamide","volume":"857","author":"Houser","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2006.07.024_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3940(98)00621-1","article-title":"The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder","volume":"253","author":"Jaggar","year":"1998","journal-title":"Neurosci. Lett."},{"issue":"9","key":"10.1016\/j.ejphar.2006.07.024_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"1","author":"Kathuria","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2006.07.024_bib25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/0929867306666220401153732","article-title":"The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic?","volume":"6","author":"Lambert","year":"1999","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2006.07.024_bib26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0091-3057(91)90349-7","article-title":"Behavioral, biochemical and molecular modeling evaluations of cannabinoid analogs","volume":"40","author":"Martin","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2006.07.024_bib27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2006.07.024_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-2999(96)00015-5","article-title":"N-(2-hydroxyethyl) hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation","volume":"300","author":"Mazzari","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.07.024_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/bbrc.1999.1105","article-title":"Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors","volume":"262","author":"Melck","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2006.07.024_bib30","first-page":"217","article-title":"Prevention of writhing and other effects of narcotics and narcotic antagonists in mice","volume":"160","author":"Pearl","year":"1968","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.07.024_bib31","first-page":"608","article-title":"The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord","volume":"279","author":"Pugh","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.07.024_bib32","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1006\/bbrc.2001.5518","article-title":"R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism","volume":"286","author":"Ramer","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2006.07.024_bib33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0197-0186(99)00020-0","article-title":"Cannabinoid receptor and WIN-55,212-2-stimulated [35S] GTP\u03b3S binding and cannabinoid receptor mRNA levels in several brain structures in adult male rats chronically exposed to R-methanandamide","volume":"34","author":"Romero","year":"1999","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2006.07.024_bib34","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.bjp.0703850","article-title":"Structure-activity relationship for the endogenous cannabinoid, anadamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens","volume":"132","author":"Ross","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.07.024_bib36","first-page":"1381","article-title":"Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice","volume":"268","author":"Smith","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.07.024_bib37","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-3057(98)00012-4","article-title":"The enhancement of morphine antinociception in mice by \u03949-tetrahydrocannabinol","volume":"60","author":"Smith","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.ejphar.2006.07.024_bib43","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1309\/7AYY-VVH1-GQT5-J4R2","article-title":"Vanilloid (capsaicin) receptors in health and disease","volume":"118","author":"Szallasi","year":"2002","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ejphar.2006.07.024_bib38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0166-2236(00)01630-1","article-title":"New perspectives on enigmatic vanilloid receptors","volume":"23","author":"Szallasi","year":"2000","journal-title":"Trends Neurosci."},{"issue":"11","key":"10.1016\/j.ejphar.2006.07.024_bib44","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1021\/jm030560j","article-title":"Vanilloid receptor TRPV1 antagonist as the next generation of painkillers. Are we putting the cart before the horse?","volume":"47","author":"Szallasi","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2006.07.024_bib39","series-title":"Procedures 5 and 8 in Manual of Pharmacologic Calculations with Computer Programs","author":"Tallarida","year":"1987"},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2006.07.024_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(97)01342-2","article-title":"Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems","volume":"45","author":"Welch","year":"1997","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejphar.2006.07.024_bib41","first-page":"1235","article-title":"Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception","volume":"273","author":"Welch","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.07.024_bib42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nature"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299906007540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299906007540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T02:50:59Z","timestamp":1736477459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299906007540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":43,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0014299906007540"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2006.07.024","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}